Delivery Order SPE2DB20D1004-SPE2DB24FG3E1

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus Solostar insulin pens. The $2,755.71 Firm Fixed Price delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,827.38 firm fixed price delivery order is for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract has a completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order valued at $1,187.60 with a firm-fixed price. It is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens, a critical medication used to manage diabetes. The award has an ultimate completion date of August 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens. The $2,375.20 firm fixed price delivery order has a completion date of June 3, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,035.55 firm-fixed-price delivery order is for Lantus Solostar insulin pens, a critical medication for diabetes management. The contract has a completion date of July 24, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of Lantus Solostar insulin pens. The contract has a ceiling value of $1,768.16 and a completion date of May 22, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,187.60 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. The contract has an ultimate completion date of August 6, 2024 and is not set aside for any special designations. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens to the Defense Logistics Agency (DLA). The $1,462.71 fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lantus Solostar insulin pens to the U.S. government. The $1,119.16 firm fixed-price delivery order was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA). Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Lantus Solostar 100 unit/ml 3ml insulin pens. The $4,271.72 firm fixed-price delivery order has a completion date of January 31, 2022 and was awarded on January 28, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG3E1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,187.60, is a delivery order for the supply of Lantus Solostar insulin pens. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 1:36 PM